Skip to content

Powder of Shwashkuthar Ras administered through the nasal route in patients with Tension-Type Headache

Clinical study to Evaluate Efficacy and Tolerability of Shwashkuthar Ras (Pradhman Nasya) in Vatika Shiroroga - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/074673
Enrollment
30
Registered
2024-10-03
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G442- Tension-type headache

Interventions

None listed

Sponsors

Gurukul Campus UAU Haridwar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patients from the Age group between 20-50. 2)Patient will be selected irrespective of sex, religion, occupation etc. 3)Patients with classical signs and symptoms of Vatika Shiroroga will be selected from OPD and IPD of Gurukul campus hospital UAU Haridwar. 4)Patients fulfilling ICHD3 criteria for Tension-Type of Headache 5) Patients previously treated with medicines or therapies for Vatika Shirorog

Exclusion criteria

Exclusion criteria: 1)Known case of Sinusitis 2)Any other types of infections associated with fever. 3) Any pathology involving the eyes. 4) Uncontrolled Hypertension 5) Diabetes mellitus 6)Migraine, Cluster headache, Trigeminal neuralgia 7)Known cases of Seizures 8)Any other serious systemic illness. 9)Secondary headache arising due to meningitis, tumor, cervical spondylosis, etc. 10) Patients who are intolerant to Pradhman Nasya

Design outcomes

Primary

MeasureTime frame
Relief in Subjective Parameters like: 1) Bitemporal Headache 2) Pain in the Occipital Region 3) Pain and burning in the Frontal region 4) Pain in eyes as if eyes are coming out 5) Severe Pain in the Ears 6) Giddiness 7) Pain as if joints are laxed 8) Disturbed sleep 9) Excessive pain at night Timepoint: 1st day,35 day

Secondary

MeasureTime frame
Relief in sign and symptoms of Vatika ShirorogaTimepoint: 1st, 35th day

Countries

India

Contacts

Public ContactDr Mayank Bhatkoti

Gurukul Campus UAU Haridwar

mayankbhatkotimd@gmail.com08979505188

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026